Un estudio económico sobre asma en México

Revista Alergia Mexico

Volumn 47, Issue 3, 2000, Pages 96-99

  Galván, Mario Cavazos ^a   Castillo, Julio Contreras ^a   Llano, Esteban Martinez ^a   Duque, David Soni ^a  

^a Clínica Nova   (Mexico)

Author keywords

Bronchial asthma; Direct costs; Indirect costs

Indexed keywords

ARTICLE; ASTHMA; COST OF ILLNESS; ECONOMICS; HEALTH CARE COST; HUMAN; MEXICO;

ASTHMA; COST OF ILLNESS; HEALTH CARE COSTS; HUMANS; MEXICO;

EID: 0006308673     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. American Lung Association. Trends in asthma morbidity and mortality. Epidemiology and Statistics Unit. November, 1998.
2. Clark TJH. Socioeconomic approach to asthma in developed and developing countries. Allergy Clin Immunol. News 1995; 7:100.
3. Weiss KB, Gergen PL, Hudgson TA, An economic evaluation of asthma in the United States. N Engl. J Med 1992; 326(13):861.
4. Canseco CG, Leal LH, Epidemiología de las enfermedades alérgicas en el área metropolitana de Monterrey. Alergia México 1991;38:95.
5. Wissow LS, Gittelsohn AM. Poverty, race and hospitalization for childhood asthma. Am J Public Health 1988;78:777.
6. Perrin JM, Homer CL. Variations in rates of hospitalization of children in three urban communities. N Engl J Med 1989; 320:1183.
7. Hughes DM, Mcload M, Garner B. Controlled trials of a home and ambulatory program for asthmatic children. Pediatrics 1991; 87:54.
8. Mayo PH, Richman L, Harris HW. Results of a program to reduce admissions for adult asthma. Ann Intern Med 1990;112: 864.
9. Rutten Van M et al. Cost effectiveness of inhaled corticosteroid plus bronchodilator therapy versus bronchodilator monoterapy in children with asthma. Pharmaco Economics 1993;4:21-27.